Drug Profile
Research programme: islet cell autoantigen 1 therapeutics - Inhibiton Therapeutics
Alternative Names: ICA-1Latest Information Update: 12 Jan 2011
Price :
$50
*
At a glance
- Originator Inhibiton Therapeutics
- Class
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 05 Dec 2007 Preclinical trials in Cancer in USA (unspecified route)